Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 5.74 is in line with its 5-year average of 5.61, near the low end of its 5-year range (0.25–29.06).
As of the fiscal period ended Tuesday, June 30, 2026. 8.47% below its 12-month average of 6.27.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.74.
CURRENT RATIO
5.74
CURRENT RATIO AVG TTM
6.27
CURRENT RATIO AVG 3Y
5.23
CURRENT RATIO AVG 5Y
5.61
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-8.47%
CURRENT VS 3Y AVG
+9.68%
CURRENT VS 5Y AVG
+2.20%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.59
median of 775 covered companies
CURRENT VS SECTOR MEDIAN
+59.83%
vs the sector median at left
Market Cap
$64.09M
Current Ratio
9.90
TTM Avg
11.46
3Y Avg
13.71
5Y Avg
15.39
Market Cap
$64.39M
Current Ratio
2.49
TTM Avg
2.38
3Y Avg
2.41
5Y Avg
2.71
Market Cap
$61.77M
Current Ratio
10.98
TTM Avg
17.43
3Y Avg
9.10
5Y Avg
12.08
Market Cap
$59.67M
Current Ratio
2.37
TTM Avg
7.60
3Y Avg
7.51
5Y Avg
12.19
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| RenovoRx, Inc. (RNXT) | $64.65M | 5.74 | 6.27 | 5.23 | 5.61 |
| Gossamer Bio, Inc. (GOSS)vs › | $65.02M | 0.53 | 4.76 | 5.20 | 7.10 |
| InterCure Ltd. (INCR)vs › | $63.14M | 1.48 | 1.60 | 1.69 | 1.84 |
| Pliant Therapeutics, Inc. (PLRX)vs › | $64.09M | 9.90 | 11.46 | 13.71 | 15.39 |
| Heron Therapeutics, Inc. (HRTX)vs › | $64.39M | 2.49 | 2.38 | 2.41 | 2.71 |
| Cingulate Inc. (CING)vs › | $65.33M | 3.50 | 1.85 | 1.22 | 3.58 |
| Alps Group Inc (ALPS)vs › | $63.23M | 0.36 | 0.31 | 0.29 | 1.05 |
| Kalaris Therapeutics Inc (KLRS)vs › | $61.77M | 10.98 | 17.43 | 9.10 | 12.08 |
| Connect Biopharma Holdings Limited (CNTB)vs › | $59.67M | 2.37 | 7.60 | 7.51 | 12.19 |
| Fortress Biotech, Inc. (FBIO)vs › | $68.27M | 3.96 | 1.88 | 1.73 | 2.58 |
Current Ratio
5.74
Quick Ratio
5.53
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 5.74 |
| 2026-03-31 | 7.15 |
| 2025-12-31 | 4.02 |
| 2025-09-30 | 5.83 |
| 2025-06-30 | 8.61 |
| 2025-03-31 | 9.07 |
| 2024-12-31 | 4.10 |
| 2024-09-30 | 5.66 |
| 2024-06-30 | 9.16 |
| 2024-03-31 | 1.54 |
| 2023-12-31 | 1.25 |
| 2023-09-30 | 2.19 |
| 2023-06-30 | 3.70 |
| 2023-03-31 | 3.50 |
| 2022-12-31 | 6.59 |
| 2022-09-30 | 8.39 |
| 2022-06-30 | 10.01 |
| 2022-03-31 | 9.92 |
| 2021-12-31 | 17.36 |
| 2021-09-30 | 29.06 |
| 2021-06-30 | 0.25 |
| 2021-03-31 | 0.21 |
| 2020-12-31 | 0.47 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
